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Brinzolamide-induced retinopathy in neonatal rats:  
an alternative animal model of retinal  
neovascularization
Abstract
Background and Purpose: Neovascular retinal pathology is steel un-
certain. Thus, there is great need to investigate new modeling, diagnostic 
and treatment technologies. Brinzolamide induces a metabolic acidosis via 
an alternative biochemical mechanism (bicarbonate loss). In the present 
study the influence of brinzolamide-induced acidosis on preretinal neovas-
cularization in neonatal rat was investigated.
Materials and Methods. In our study we used newborn Wistar rats 
raised in two litters. Newborn rats (n=17) were randomized to either intra-
peritoneal brinzolamide in dose 200 mg/kg (n=9) or saline (n=8), twice 
daily from days 2 to 7. After 5 days of recovery all rats were euthanized. Six 
paraffin-embedded sections prepared in a standard manner and stained 
with hematoxylin and eosin. To investigate the damage, we evaluated the 
number of cells in the ganglion cell layer (GCL) and the thicknesses of the 
inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform 
layer (OPL), and outer nuclear layer (ONL). The cells in GCL and the 
thicknesses of the IPL, INL, and ONL at a distance between 375 and 625 
µm from the optic disc were measured.
Results: Preretinal neovascularization was found in 71% retinas, from 
brinzolamide-injected rats. Cataract formation was detected in 100% eyes 
after brinzolamide injections. All retinas from saline group were negative 
for neither neovascularization nor cataract. Brinzolamide rat model retinas 
showed decrease in the thicknesses of the retinal layers.
Conclusion: In the present study, we report that brinzolamide (a drug 
causing metabolic acidosis primarily by bicarbonate loss) is associated with 
preretinal neovascularization in the neonatal rat. So this method can be 
suitable model for other neovascular pathologies of the eye.
INTRODUCTION
Many blinding retinal diseases, including diabetic retinopathy, age related macular degeneration, retinopathy after central retinal 
vein occlusion, and branch retinal vein occlusion and retinopathy of 
prematurity, involve the development of abnormal vasculature (1, 2, 3, 
4). Numerous clinical and experimental observations have indicated that 
ischemia with following hypoxia and acidosis of nervous tissue is the 
main cause for retinal neovascularization. Stimulation of angiogenesis 
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is performed by various angiogenic proteins, including 
several growth factors, whereas the VEGF family has been 
demonstrated to be a major contributor to angiogenesis 
(1, 3, 5). At least five retinal cell types have the ability to 
produce VEGF. These include the retinal pigmented epi-
thelium, astrocytes, Muller cells, endothelial and gan-
glion cells. However, they differ widely in their responses 
to hypoxia; in vitro studies show that Muller cells and 
astrocytes generally produce the greatest amounts of 
VEGF in hypoxic and acidosis conditions (4, 5, 6). Ani-
mal models of oxygen-induced retinopathy have become 
major models for pathological angiogenesis resulting from 
ischemia. Studies suggest, excess CO2 inhalation, NH4Cl 
gavage and intraperitoneal acetozolamide in the neonatal 
rat produce an acidosis-induced retinopathy which serves 
as a model for neovascular retinopathy (7, 8, 9). Carbo-
anhydrase inhibitors (CAI) induce a metabolic acidosis 
via an alternative biochemical mechanism (bicarbonate 
loss versus hydrogen ion load) (9, 10). The only solution 
of CAI, released in Ukraine is brinzolamide. In the pres-
ent study the influence of brinzolamide-induced acidosis 
on preretinal neovascularization in neonatal rat was in-
vestigated.
mATERIALS AND mETHODS
In our study we used newborn Wistar rats raised in 
two litters. Animals were treated according to European 
Convention for the Protection of Vertebrate Animals used 
for Experimental and Other Scientific Purposes (Stras-
bourg, 18.III.1986). The rats were kept under controlled 
lighting conditions (12:12-h light/dark). Newborn rats 
(n=17) were randomized to either intraperitoneal brinzo-
lamide in dose 200 mg/kg (n=9) or saline (n=8), twice 
daily from days 2 to 7. After 5 days of recovery direct 
ophthalmoscopy was performed. All brinzolamide-inject-
ed animals had dense lenticular opacification. Saline-in-
jected rats were negative for cataract formation. The 
opaque region was always restricted to the center of the 
lens. It was impossible to recognize retinal changes under 
ophthalmoscopy in brinzolamide group. At the same day 
all rats were euthanized. Each eye was enucleated and 
kept immersed for at least 21 day at 4°C in a fixative solu-
tion containing 4% paraformaldehyde. Six paraffin-em-
bedded sections (thickness, 5 µm) cut through the optic 
disc of each eye were prepared in a standard manner and 
stained with hematoxylin and eosin. Light microscope 
images were photographed using a digital camera. To in-
vestigate the damage in each retinal layer after intraperi-
toneal brinzolamide or saline injections, we evaluated the 
number of cells in the ganglion cell layer (GCL) and the 
thicknesses of the inner plexiform layer (IPL), inner nu-
clear layer (INL), outer plexiform layer (OPL), and outer 
nuclear layer (ONL). The cells in GCL and the thick-
nesses of the IPL, INL, and ONL at a distance between 
375 and 625 µm from the optic disc were measured on 
the photographs in a masked fashion by a single observer.
RESULTS
All retinas from saline group were negative for neovas-
cularization (Fig. 1).
Preretinal neovascularization was found in 71% reti-
nas, from brinzolamide-injected rats. Newly formed cap-
illaries were found above the internal limiting membrane 
(ILM) in a mid- and far retinal periphery, prominated in 
the vitreous cavity. The capillary wall consists of single 
endothelial cell layer and its basement membrane. Eryth-
rocytes were found in the capillary lumen (Fig. 2).
Brinzolamide rat model retinas showed decrease in the 
thicknesses of the IPL, OPL, INL and ONL compared 
to those in normal rat retinas. There were no significant 
differences in the number of cells in the GCL between 
the brinzolamide model and normal rats’ retinas. How-
ever the depth of the GCL varied significantly between 
experimental groups (Tab.1).
Bilateral cataract formation in all brinzolamide-inject-
ed rats was the side effect, so ophthalmoscopy was not 
Figure 1. Normal rat retina. Hematoxylin-eosin staining. ×100
Figure 2. Neovascular tufts above ILM, in the vitreous cavity, near 
by lens posterior capsule. Hematoxylin-eosin staining. ×100
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Hence, brinzolamide induces excessive loss of bicar-
bonate via the kidneys. It leads to metabolic acidosis and 
results tissue hypoxia. Neural cells in hypoxic conditions 
start to produce angiogenic factors, among them VEGF. 
Angiogenic factors turn on neovascularization cascade.
DISCUSSION
There is well known oxygen-induced neovascular reti-
nopathy animal model. Oxygen using needs special pre-
cautions and consumes labor-intensive manipulations.
Metabolic acidosis involves a decreased serum HCO3 
concentration along with a decrease in pH. In metabolic 
acidosis, the body compensates for the decrease in pH by 
increasing the respiratory rate in an effort to decrease 
PCO2 and H2CO3 levels. Metabolic acidosis can be 
caused by one or more of the following four mechanisms: 
increased production of fixed metabolic acids or ingestion 
of fixed acids such as salicylic acid, inability of the kidneys 
to excrete the fixed acids produced by normal metabolic 
processes, excessive loss of bicarbonate via the kidneys or 
gastrointestinal tract, or an increased serum Cl concentra-
tion (13). Indeed other studies suggest, excess CO2 inha-
lation, NH4Cl gavage and intraperitoneal acetozolamide 
in the neonatal rat produce an acidosis-induced neovas-
cular retinopathy (6, 8, 10).
CO2 application requires expensive laboratory equip-
ment with hermetic gas contour. NH4Cl gavage is related 
to technical problems: putting feeding intestinal tube into 
neonatal rat’s stomach.
We can’t apply acetazolamide injections, because this 
medicine didn’t release in Ukraine. So we decided to cre-
ate available, simple, cheap, safe and less labor-consuming 
experimental model of neovascular retinopathy. In our 
study we used brinzolamide, carboanhidrase inhibitor. 
We needed just sterile syringe 28G, sterile 0,1% brinzol-
amide solution, preoperative injection site preparation 
with betadine. Introperitoneal injection is technically 
simple procedure.
Preretinal neovascularisation occurred in 71% rats re-
ceived high dose brinzolamide compared to 59% in acet-
azolamide study. Pathology retinal findings from experi-
mental animals were similar to those in acetazolamide 
study (10).
Brinzolamide and acetazolamide have the same fairly 
well protein-bound (60%), but brinzolamide’s whole half-
life is very long (111 days in human) compared to hours 
in acetazolamide. We suppose that this is key point of 
brinzolamide use in neovascular retinopathy modeling 
(11, 12).
Besides, cataract formation was observed in all ani-
mals, received brinzolamide. We assume that high dose 
(200 mg/kg) brinzolamide, causing prolonged acidosis, 
leads to metabolic cataract formation.
TABLE 1
Morphometric changes in experimental rats 
retinas (μm).
Saline Brinzolamide
Mean ±SD Mean ±SD
Central zone 204 2,16 163,77* 1,8
Periph. zone 154,06 1,61 122,5* 1,33
IPL 42 2,19 39,66* 2,49
OPL 18 1,63 14,77* 1,8
INL 40,94 1,77 28* 1,53
ONL 55 1,89 35* 2,05
GCL 23,06 1,76 19* 2,05
* - significantly different from saline (?<0,05)
Figure 3. Swelling of the lens capsule; hematoxylin-eosin staining x 
1000, immersion.
Figure 4. Proliferation of epithelial cells; hematoxylin-eosin staining 
x 1000, immersion.
performed. We founded swelling of the lens capsule 
(Fig.3), proliferation of epithelial cells (Fig.4), vacuoliza-
tion of the hyaline layer, disorder or collapse of the lens.
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In conclusion, in the present study we report that 
brinzolamide (a drug causing metabolic acidosis primar-
ily by bicarbonate loss) is associated with preretinal neo-
vascularization in the neonatal rat. Retinal neovascular-
ization was found above the internal limiting membrane 
in mid- and far periphery. So this method can be suitable 
model for other neovascular pathologies of the eye such 
as diabetic retinopathy, age related macular degeneration, 
retinopathy after central retinal vein occlusion, and 
branch retinal vein occlusion and retinopathy of prema-
turity. The side effect of intraperitonel bronzolamide in-
jections was cataract formation. This animal model is 
much safer then oxygen-induced one, because no explo-
sive gas is used.
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